In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Faustine RavonUnit of Microbiology, Bioorganic and Macromolecular Chemistry, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium.
Emilie BernsUnit of Microbiology, Bioorganic and Macromolecular Chemistry, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium.
Isaline LambertUnit of Microbiology, Bioorganic and Macromolecular Chemistry, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium.ORCID 0009-0005-0485-6804 Céline RensUnit of Microbiology, Bioorganic and Macromolecular Chemistry, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium.
Pierre-Yves AdnetUnit "Tuberculosis & Mycobacteria", Human Bacterial Diseases, Sciensano, 1180 Brussels, Belgium.
Mehdi KiassUnit "Tuberculosis & Mycobacteria", Human Bacterial Diseases, Sciensano, 1180 Brussels, Belgium.
Véronique MegalizziUnit of Microbiology, Bioorganic and Macromolecular Chemistry, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium.ORCID 0000-0003-4229-5022 Cédric DelporteUnit of Pharmacognosy, Bioanalysis and Drug Discovery & Analytical Platform of the Faculty of Pharmacy (APFP), Faculty of Pharmacy, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.ORCID 0000-0001-7453-7028 Alain BaulardCentre d'Infection et d'Immunité de Lille, Institut Pasteur de Lille, Université de Lille, CNRS, Inserm, U1019-UMR9017, 59000 Lille, France.
Vanessa MathysUnit "Tuberculosis & Mycobacteria", Human Bacterial Diseases, Sciensano, 1180 Brussels, Belgium.ORCID 0000-0001-5218-927X Samira BoarbiUnit "Tuberculosis & Mycobacteria", Human Bacterial Diseases, Sciensano, 1180 Brussels, Belgium.
Nathalie WauthozUnit of Pharmaceutics and Biopharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium.ORCID 0000-0003-2445-5790 Véronique FontaineUnit of Microbiology, Bioorganic and Macromolecular Chemistry, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium.ORCID 0000-0001-7588-5462 Funding
Fund for Scientific Research CDR J.0194.21Innoviris RBC/2021-POC2
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
macrophage infection modelorlistatpulmonary deliverytuberculosisvancomycin
Identifiers
PMID40574018
PMCPMC12195745
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390